Migraine treatment encompasses various applications, including acute relief and preventive measures. Advantages of effective migraine treatment include reduced frequency and intensity of migraine attacks, improved quality of life, and enhanced productivity. Key features of migraine treatment options involve diverse drug classes targeting specific pathways, such as triptans, CGRP antagonists, and nonsteroidal anti-inflammatory drugs. Additionally, lifestyle modifications and behavioral therapies play a crucial role in managing migraines, providing a comprehensive approach to alleviate symptoms and improve the overall well-being of individuals affected by migraines.
According to Data Bridge Market Research, the Global Migraine Treatment Market is accounted at USD 2.38 billion in 2021 and is expected to reach USD 4.67 billion by 2029. The market is expected to grow with a CAGR of 8.80% in the forecast period of 2022 to 2029.
“Increasing prevalence of migraines and improved diagnosis rates boosts the market’s growth”
The migraine treatment market experiences growth due to the increasing prevalence of migraines and improved diagnosis rates. As awareness of migraines and their impact on individuals' quality of life grows, more people seek medical attention and diagnosis for their symptoms. This rising demand for migraine treatment drives pharmaceutical companies to invest in research and development, leading to the introduction of innovative therapies. With a larger patient pool and advancing treatment options, the market expands to cater to the needs of those suffering from migraines.
What restraints the growth of the global migraine treatment market?
“Alternative therapies restraints the market’s growth”
The migraine treatment market's growth is restrained by alternative therapies used by some patients. Some individuals may choose alternative treatments, such as herbal remedies or acupuncture, as a primary or supplementary approach to managing migraines. This preference for alternative therapies can lead to reduced demand for conventional migraine medications, impacting the market's growth potential. Additionally, the lack of clinical evidence and regulatory approvals for some alternative therapies may also contribute to the market's challenges in gaining widespread acceptance.
Segmentation: Global Migraine Treatment Market
The global migraine treatment market is segmented on the basis of type, treatment, route of administration, product, distribution channel, and end-user.
- On the basis of type, the global migraine treatment market is segmented into episodic, migraine with aura, chronic, and others.
- On the basis of treatment, the global migraine treatment market is segmented into acute/abortive treatment, preventive/prophylactic treatment, non-pharmacological therapies, and devices.
- On the basis of route of administration, the global migraine treatment market is segmented into oral, parenteral, nasal sprays and others.
- On the basis of product type, the global migraine treatment market is segmented into prescription and over the counter.
- On the basis of type, the global migraine treatment market is segmented into branded and generic.
- On the basis of distribution channel, the global migraine treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.
- On the basis of end-user, the global migraine treatment market is segmented into hospitals, clinics, homecare, others.
Regional Insights: North America is dominating the Global Migraine Treatment Market
North America is a dominating region in the global migraine treatment market due to well-established pharmaceutical sector. Additionally, the region's in-depth awareness of the debilitating impact of migraines on quality of life drives a significant demand for migraine drugs. This substantial need for effective treatments in North America further contributes to the region's prominence in the market.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-migraine-treatment-market
Recent Developments
- In February 2022, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) granted a favorable opinion to Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, developed by Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. The orally dissolving tablet, available in a 75 mg dose, is recommended for marketing authorization.
- In January 2022, Elyxyb (celecoxib oral solution) from BioDelivery Sciences is an innovative fast-acting liquid. It stands as one of the first FDA-approved ready-to-use oral treatments specifically designed for individuals experiencing acute migraine with or without aura.
The Prominent Key Players Operating in the Global Migraine Treatment Market Include:
- Pfizer Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Amgen Inc. (U.S.)
- GlaxoSmithKline plc. (U.K.)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Allergan (Ireland)
- Abbott (U.S.)
- Allodynic Therapeutics, LLC (U.S.)
- AOBiome (U.S.)
- AstraZeneca (U.K)
- Aurobindo Pharma USA (U.S.)
- Bausch Health Companies Inc. (Canada)
- Biohaven Pharmaceuticals (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Catalent, Inc (U.S.)
- Dr. Reddy’s Laboratories Ltd. (India)
- Impel Pharmaceuticals Inc. (U.S.)
- H. Lundbeck A/S (Denmark)
- Merck & Co., Inc (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global migraine treatment market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Migraine Treatment Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
